Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
"Global Cell Therapy Technologies Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global cell therapy technologies market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global cell therapy technologies market report has been segmented on the basis of product, cell type, process stages, end user, and region.
Cell therapy technologies are solutions for the development of cell therapy such as cell processing, cell banking, and point-of-care technologies. The technologies overlap gene therapy, tissue engineering, cancer vaccines, and regenerative medicines. It is used to determine unique diseases susceptibility which in turn helps to take preventive measures for the treatment of diseases. Cell therapy technologies are developed for niche indications with high unmet need.
Rising demand for oncology-oriented cell-based therapy clinical trials, is a major factor expected to drive growth of the global cell therapy technologies market over the forecast period. In addition, increasing demand for advanced cell therapy instruments, owing to its affordability and sustainability, is another factor anticipated to fuel growth of the target market in the next coming years. Moreover, increasing government investments in cell-based research therapy for life-style diseases such as diabetes, is among some factor estimated to drive growth of the potential market over the forecast period.
However, high cost of cell-based research and low success rate is a factor which may hamper demand for cell therapy technologies and restrain growth of the target market over the forecast period. Increasing adoption of cell therapy technologies in developing countries is a factor expected to create a lucrative opportunity for growth of the global cell therapy technologies market over the forecast period.
On the basis of product, the consumables segment is expected to account for highest revenue share in the target market over the forecast period. Among cell type, the human cells segment is anticipated to register for major share in terms of revenue in the target market over the long run. Among process stages, the cell processing segment is projected to grow at a faster rate in the target market over the forecast period. Among end user, the life science research companies segment is anticipated to register for significant share in terms of revenue in the global cell therapy technologies market over the forecast period.
The cell therapy technologies market in North America holds major share contribution in terms of revenue in the target market and is expected to maintain its dominance over the forecast period. Rising demand for cell therapy technologies in medical sector owing to increasing number of chronic diseases in countries in the region is expected drive revenue growth of the North America cell therapy technologies market over the forecast period. The market in Europe is projected to grow at a significant rate in the global cell therapy technologies market over the forecast period followed by North America. The Asia Pacific cell therapy technologies market is projected to witness fastest growth rate in the target market over the forecast period.
Market Segmentation and Key Players Operating in the Global Cell Therapy Technologies Market:
Segmentation on the Basis of Product:
- Systems & Software
Segmentation on the Basis of Cell Type:
- Human Cells
- Animal Cells
Segmentation on the Basis of Process Stages:
- Cell Processing
- Cell Preservation, Distribution, and Handling
- Process Monitoring and Quality Control
Segmentation on the Basis of End User:
- Life Science Research Companies
- Research Institutes
Segmentation on the Basis of Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- TERUMO BCT, INC. (A Subsidiary of Terumo Corporation)
- Lonza Group Ltd.
- GE Healthcare Inc.
- Sartorius AG
- Becton, Dickinson and Company
- Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- Miltenyi Biotec GmbH
- STEMCELL Technologies Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!